Literature DB >> 14984940

Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis.

Alessandro Sgambato1, Gian Franco Zannoni, Beatrice Faraglia, Andrea Camerini, Elisabetta Tarquini, Daniele Spada, Achille Cittadini.   

Abstract

OBJECTIVE: The expression of the CDK inhibitor p27Kip1 and the extent of endogenous oxidative DNA damage were evaluated in the multistep cervical carcinogenesis.
METHODS: Archival specimens of low-grade (L) squamous intraepithelial lesions (SILs) (n=32), high-grade (H) SILs (n=24) and invasive carcinomas (n=48) of the cervix were included in the analysis compared with normal cervical squamous epithelium (n=15). Expression level of p27Kip1 was evaluated by immunostaining. Immunohistochemical detection of 8-hydroxydeoxyguanosine (8-OHdG) was considered as marker of oxidative DNA damage in the same tissues.
RESULTS: p27Kip1 was constantly expressed in normal epithelium with a mean percentage of positive cells higher than 50%. A progressive significant reduction in the mean percentage of positive cells was observed in L-SIL (18.1%), H-SIL (7.3%) and in invasive carcinomas (2.5%). A progressive significant increase in the levels of 8-OHdG and in the percentage of mean positive cells was observed from L-SIL (2.2%) to H-SIL (12.5%) to invasive carcinomas (25.2%). p27Kip1 and 8-OHdG expression displayed a significant inverse relationship.
CONCLUSIONS: Expression of p27Kip1 is down-regulated while oxidative DNA damage increases during cervical carcinogenesis. Both parameters are altered at early stages of the process and might help to predict patients at high risk of progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984940     DOI: 10.1016/j.ygyno.2003.12.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

Review 2.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

3.  Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.

Authors:  Géssica Lima; Erinaldo Santos; Hildson Angelo; Micheline Oliveira; Sandra Heráclio; Fernanda Leite; Celso de Melo; Sergio Crovella; Maria Maia; Paulo Souza
Journal:  Tumour Biol       Date:  2016-02-17

4.  A study of oxidative stress in cervical cancer- an institutional study.

Authors:  Kulsoom Zahra; Sandeep Patel; Tulika Dey; Uma Pandey; Surendra Pratap Mishra
Journal:  Biochem Biophys Rep       Date:  2020-12-29

5.  A study on UHPLC-MS/MS analyses of DNA and RNA oxidative damage metabolites in patients with cervical carcinoma: 8-oxoG in urine as a potential biomarker of cervical carcinoma.

Authors:  Rong-Rong Lin; Xiang-Yu Li; Qing-Hua Weng; Xing-Xing Zhou; Fei-Yun Zheng; Jian-Ping Cai
Journal:  Heliyon       Date:  2022-04-25

Review 6.  Oxidative stress and HPV carcinogenesis.

Authors:  Federico De Marco
Journal:  Viruses       Date:  2013-02-12       Impact factor: 5.048

Review 7.  Emerging biological treatments for uterine cervical carcinoma.

Authors:  Patrizia Vici; Luciano Mariani; Laura Pizzuti; Domenico Sergi; Luigi Di Lauro; Enrico Vizza; Federica Tomao; Silverio Tomao; Emanuela Mancini; Cristina Vincenzoni; Maddalena Barba; Marcello Maugeri-Saccà; Giuseppe Giovinazzo; Aldo Venuti
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

8.  Lipid Peroxidation, Antioxidative Defense and Level of 8-hydroxy-2-deoxyguanosine in Cervical Cancer Patients.

Authors:  Marija Jelić; Aljoša Mandić; Nebojša Kladar; Jan Sudji; Biljana Božin; Branislava Srdjenović
Journal:  J Med Biochem       Date:  2018-07-01       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.